| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2012 | AMYLIN PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination |
$170,000 | |
| 2012 | AMYLIN PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$260,000 | |
| 2012 | AMYLIN PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$340,000 | |
| 2011 | AMYLIN PHARMACEUTICALS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$240,000 | |
| 2011 | AMYLIN PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$250,000 | |
| 2011 | AMYLIN PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$230,000 | |
| 2011 | AMYLIN PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$240,000 | |
| 2010 | AMYLIN PHARMACEUTICALS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$200,000 | |
| 2010 | AMYLIN PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$200,000 | |
| 2010 | AMYLIN PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$240,000 |
| Firm | Filings | Expenses |
|---|---|---|
| AMYLIN PHARMACEUTICALS | 24 | $6,235,750 |
| Issue | Activities |
|---|---|
| Medicare/Medicaid | 22 |
| Copyright/Patent/Trademark | 20 |
| Pharmacy | 20 |
| Budget/Appropriations | 19 |
| Health Issues | 19 |
| Medical/Disease Research/Clinical Labs | 14 |
| Consumer Issues/Safety/Products | 4 |
| Taxation/Internal Revenue Code | 3 |
| Veterans | 3 |